Protagonist Therapeutics, Inc. (PTGX)

104.49 -1.40 (-1.32%) USD  |  NASDAQ  |  Apr 22, 11:49
More

Protagonist Therapeutics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Johnson & Johnson Upgrade
AbbVie, Inc. Upgrade
Insmed, Inc. Upgrade
Madrigal Pharmaceuticals, Inc. Upgrade
PTC Therapeutics, Inc. Upgrade